Topic: Optimization of Cholesterol/Polycaprolactone-based Perfluorooctyl Bromide Nanocapsules and Its Impact on X-ray CT Attenuation for Tumor Imaging
André Beringhs is a Ph.D. candidate in Pharmaceutical Sciences (Pharmaceutics) at the University of Connecticut, School of Pharmacy. André is passionate about drug delivery and improving the standard of care in human health. During his academic training, André has focused on multidisciplinary projects ranging from oral drug product development to exploratory nanoparticle-based parenteral delivery systems. His multidisciplinary approach to research led to more than 24 scientific publications and 4 patent applications. At the University of Connecticut, André has been working on the development of nanoparticle-based contrast agents employing novel excipients to enable the next generation of medical imaging applications. Tumor imaging has been a major focus of his research as he believes a better understanding of tumor characteristics is of upmost importance for the development of improved delivery systems for cancer therapy.